Abstract:The retinoic acid receptor-related orphan receptor (ROR) γt receptor is a member of nuclear receptors, which is indispensable for the expression of pro-inflammatory cytokine IL-17. RORγt has been established as a drug target to design and discover novel treatments for multiple inflammatory and immunological diseases. It is important to elucidate the molecular mechanisms of how RORγt is activated by an agonist, and how the transcription function of RORγt is interrupted by an inverse agonist. In this study we performed molecular dynamics simulations on four different RORγt systems, i.e., the apo protein, protein bound with agonist, protein bound with inverse agonist in the orthosteric-binding pocket, and protein bound with inverse agonist in the allosteric-binding pocket. We found that the orthosteric-binding pocket in the apo-form RORγt was mostly open, confirming that apo-form RORγt was constitutively active and could be readily activated (ca. tens of nanoseconds scale). The tracked data from MD simulations supported that RORγt could be activated by an agonist binding at the orthosteric-binding pocket, because the bound agonist helped to enhance the triplet His479–Tyr502–Phe506 interactions and stabilized H12 structure. The stabilized H12 helped RORγt to form the protein-binding site, and therefore made the receptor ready to recruit a coactivator molecule. We also showed that transcription function of RORγt could be interrupted by the binding of inverse agonist at the orthosteric-binding pocket or at the allosteric-binding site. After the inverse agonist was bound, H12 either structurally collapsed, or reorientated to a different position, at which the presumed protein-binding site was not able to be formed.

Effect of ROR γt on regulation of IFN-γ secretion of T cell subpopulations (90.15)

Ifr-9/Stat2 Functional Interaction Drives Retinoic Acid-Induced Gene G Expression Independently Of Stat1

Retinoid-Related Orphan Receptor Gamma T is A Potential Therapeutic Target for Controlling Inflammatory Autoimmunity

Correction: RORγt Represses IL-10 Production in Th17 Cells to Maintain Their Pathogenicity in Inducing Intestinal Inflammation

Small-molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms.

Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases

The Role of STAT3 in Antigen-Igg Inducing Regulatory CD4+Foxp3+T Cells

Generation of ROR gamma t(+) Antigen Specific T Regulatory 17 Cells from Foxp3(+) Precursors in Autoimmunity

Effect of CpG ODN on the Differentiation of Treg/Th17 Cells

Small-Molecule Ror Gamma T Antagonists: One Stone Kills Two Birds

Regulatory Effects of IFN-γ on Treg Cells from HIV/AIDS Patients Receiving HAART for One Year

Reciprocal Regulation of RORγt Acetylation and Function by P300 and HDAC1

Molecular Dynamics Simulations on RORγt: Insights into Its Functional Agonism and Inverse Agonism

FOXP3 and RORγt: transcriptional regulation of Treg and Th17.

[A novel molecular mechanism of interferon alpha-regulated expression of retinoic acid-induced gene G]

Increasing human Th17 differentiation through activation of orphan nuclear receptor retinoid acid-related orphan receptor γ (RORγ) by a class of aryl amide compounds.

[RGS1 is involved in the regulation of co-stimulatory molecules and cytokines in RAW264.7 cells].

Romance of the three kingdoms: RORgammat allies with HIF1alpha against FoxP3 in regulating T cell metabolism and differentiation

Lack of IFN-γ Receptor Signaling Inhibits Graft-versus-Host Disease by Potentiating Regulatory T Cell Expansion and Conversion.

Retinoic Acid-induced Transcriptional Modulation of the Human Interferon-γ Promoter

Interferon Regulatory Factor 8 Regulates RANTES Gene Transcription in Cooperation with Interferon Regulatory Factor-1, NF-κB, and PU.1*